Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Squamous Cell Carcinoma of the Skull Base

How We Can Help You

Squamous cell carcinoma is the most common cancer of the skull base. It accounts for two-thirds of skull base cancers and typically begins in the sinuses or nasal cavity and can extend up towards the brain.  

Treatment at an academic medical center which offers close collaboration between a team of specialists is important for the best outcomes.

Stanford is a global referral center for squamous cell carcinomas and is at the forefront of developing new, minimally invasive procedures that treat them.

WHAT WE OFFER YOU FOR SQUAMOUS CELL CARCINOMA OF THE SKULL BASE

  • Globally-recognized expertise in the diagnosis and management of squamous cell carcinoma of the skull base.
  • Team-based treatment planning that brings together specialists from neurosurgery, head and neck surgery, neuroradiology, neuropathology, neuro-ophthalmology, and more.
  • Access to advanced imaging including neuro-navigation of the brain to help surgeons more clearly distinguish tumors from sensitive surrounding tissues.
  • An active clinical research program dedicated to broadening options for the diagnosis and treatment of squamous cell carcinoma of the skull base.
  • Assistance from our International Medical Services team to plan your travel and accommodations.

Treatment Options for Squamous Cell Carcinoma of the Skull Base

Careful collaboration between a variety of specialists help focus recommendations for treatment of squamous cell carcinoma.

Surgery

In general, surgery is recommended as a primary treatment with a goal of removing all of the tumor or as much as is safe. If there is suspicion that the cancer may have spread to adjacent lymph nodes in the neck,  they may be removed during surgery and evaluated.  

Radiation Therapy

Radiation therapy is often recommended after surgery to attack any residual cancer cells.  

3:57
Endoscopic Endonasal Approach (EEA) to Skull Base
Play Video | 3:57
Endoscopic Endonasal Approach (EEA) to Skull Base
Endoscopic Endonasal Approach (EEA) to Skull Base

Drug Therapy

Chemotherapy may be added to radiation therapy, if the tumor couldn’t not be fully removed. In cases where there is significant involvement of the brain or both eyes, the primary treatment may be chemotherapy with or without radiation to shrink the tumor.

Clinical Trials for Squamous Cell Carcinoma of the Skull Base

0

Open Clinical Trials

View All

Clinical trials evaluate new approaches, devices, or medications in the treatment of squamous cell carcinoma of the skull base. Ask your doctor or clinical trials coordinator about available trials that may be additional options for your care.

To learn more about the clinical trials we offer, contact Maria Coburn at 650-736-9551.

Closed trials are not currently enrolling, but may open in the future.
View Closed Clinical Trials Clinical Trials for Squamous Cell Carcinoma of the Skull Base

What is Squamous Cell Carcinomas of the Skull Base?

About Squamous Cell Carcinomas of the Skull Base

Squamous cell carcinoma is the most common malignancy involving the skull base. It accounts for two-thirds of skull base cancers, and typically begins in the sinuses or nasal cavity and can extend up towards the brain.

At the time of diagnosis, about 10-percent of patients will have cancer that has spread to the lymph nodes of the neck. Another 20-percent will develop cancer in the lymph nodes if they are not promptly treated.

Our Clinics

Skull Base Surgery Program
Skull base surgery is a highly-specialized field that addresses tumors and other abnormalities on the underside of the brain or base of the skull.
View All Locations
Make An Appointment

To schedule an appointment, please call: 650-497-7777